Summary The Atrial Fibrillation-Market Insights
& Drugs Sales Forecast (AF) -2020 report provides an overview of the
disease, epidemiology and global market trends for the seven major markets ie:
United States, EU5 (France, Germany, Italy, Spain, UK) and Japan. According to
DelveInsight, Global Atrial Fibrillation market was $7.2 billion in 2015 and
expected to grow to $12.5 billion by 2020 with and compound annual growth rate
(CAGR) of 11.62%.

Coagulation is an important phenomenon
of body to stop external bleeding but when clots are formed in blood vessels,
it can be lethal. Blood clots in arteries can lead to heart attack and when
formed in the blood vessels of brain can lead to stroke. Thus, anticoagulants
are used to prevent the formation of blood clots in the body. Anticoagulants
are proved to be a beneficial medication for the treatment of Atrial
fibrillation, Deep Vein Thrombosis, Pulmonary Embolism and Stroke.

Key Coverage and Benefits:

• The report will help in developing
business strategies by understanding the trends shaping and driving the global
Atrial Fibrillation (AF) market. • Identifying patient populations in the
global Atrial Fibrillation (AF) market to improve product design, pricing, and
launch plans. • Organize sales and marketing efforts
by identifying the best opportunities for Atrial Fibrillation (AF) therapeutics
in each of the markets covered. • To understand the future market
competition in the global Atrial Fibrillation (AF) therapeutics market and
Insightful review of the key market drivers and barriers.

Scope of the Report:

• Report covers the disease overview
including etiology, path physiology, symptoms, diagnosis, disease management
and current treatment options. • Marketed information including
available prescription drugs, its patent and exclusivity details followed by
drug sales till 2018. • The Report also covers the detailed
global historical and forecasted epidemiological data covering United States,
EU5, Japan and rest of the word from 2015-2020.

• It also provides Atrial fibrillation
(AF) for United States, EU5 and Japan from 2015 and forecasted Market to 2020.